The Vision Council has released a new two-part research report, Focused inSights 2025: Myopia Management, offering a combined global and U.S. perspective on pediatric myopia treatment. The dual-format report compares regulatory and product availability trends internationally with survey data from U.S. eyecare providers, creating one of the most comprehensive views of current approaches to childhood myopia care.
Comparative Myopia Treatment Strategies
The first section examines treatment availability across the U.S., Canada, the U.K., and the EU, with a focus on four major categories: low-dose atropine drops, myopia control spectacle lenses, multifocal or dual-focus daily soft contact lenses, and orthokeratology.
The report highlights uneven adoption across markets, noting milestones such as the EU’s approval of Ryjunea atropine drops and France’s decision to fully reimburse myopia control spectacle lenses. It also considers financing models and prescribing practices across different regions.
Provider Approaches in the U.S.
The second section presents findings from a survey of 293 U.S. optometrists, practice owners, and managers conducted between June 16 and July 4, 2025. Key insights include:
- Proactive screening: 91% of providers recommend myopia screenings at least once a year.
- Treatment adoption: About 70% of providers report offering myopia management to children in their practice.
- Most common treatment: MiSight® contact lenses are prescribed most frequently (81%).
- Motivations: Providers cite slowing progression (78%), reducing complication risks (78%), and improving long-term eye health (71%) as leading reasons to treat.
- Risk factors: Excessive screen time (82%), genetics (82%), and limited outdoor activity (77%) were identified as the main drivers of myopia.
- Challenges: Cost (86%), parental understanding (56%), and patient compliance (49%) remain significant barriers.
“This dual-format report provides both a global and a local lens on myopia management,” said Alysse Henkel, Vice President of Research and inSights at The Vision Council. “It’s clear that U.S. providers take myopia seriously, but they also face challenges in affordability and patient education. By including an international analysis, we can see where care stands today and where it is headed.”
The full report is available through The Vision Council’s Research Download Center. Members may access the report at no cost; non-members can purchase it for $5,000.
Source: The Vision Council
Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!
